Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor.
Saved in:
| Title: | Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor. |
|---|---|
| Authors: | Medak KD; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada., Koehler JA; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada., Baggio LL; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada., Gonzalez-Rellan MJ; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada., Wong CK; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada., Cao X; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada., Rao V; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Kao S; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Cui Y; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Fu J; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Liaw E; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Kabir MG; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada., Zhang J; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Wei J; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Drucker DJ; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada. |
| Source: | JCI insight [JCI Insight] 2026 Mar 03; Vol. 11 (8). Date of Electronic Publication: 2026 Mar 03 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: eCollection Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41774502 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Medak+KD%22">Medak KD</searchLink>; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Koehler+JA%22">Koehler JA</searchLink>; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Baggio+LL%22">Baggio LL</searchLink>; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Rellan+MJ%22">Gonzalez-Rellan MJ</searchLink>; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Wong+CK%22">Wong CK</searchLink>; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Cao+X%22">Cao X</searchLink>; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Rao+V%22">Rao V</searchLink>; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kao+S%22">Kao S</searchLink>; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Cui+Y%22">Cui Y</searchLink>; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Fu+J%22">Fu J</searchLink>; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Liaw+E%22">Liaw E</searchLink>; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kabir+MG%22">Kabir MG</searchLink>; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Wei+J%22">Wei J</searchLink>; Section of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Drucker+DJ%22">Drucker DJ</searchLink>; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101676073%22">JCI insight</searchLink> [JCI Insight] 2026 Mar 03; Vol. 11 (8). <i>Date of Electronic Publication: </i>2026 Mar 03 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101676073 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2379-3708 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223793708%22">23793708 </searchLink><i>NLM ISO Abbreviation: </i>JCI Insight <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41774502 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/jci.insight.201148 Languages: – Code: eng Text: English Titles: – TitleFull: Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Medak KD – PersonEntity: Name: NameFull: Koehler JA – PersonEntity: Name: NameFull: Baggio LL – PersonEntity: Name: NameFull: Gonzalez-Rellan MJ – PersonEntity: Name: NameFull: Wong CK – PersonEntity: Name: NameFull: Cao X – PersonEntity: Name: NameFull: Rao V – PersonEntity: Name: NameFull: Kao S – PersonEntity: Name: NameFull: Cui Y – PersonEntity: Name: NameFull: Fu J – PersonEntity: Name: NameFull: Liaw E – PersonEntity: Name: NameFull: Kabir MG – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Wei J – PersonEntity: Name: NameFull: Drucker DJ IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 03 Text: 2026 Mar 03 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2379-3708 Numbering: – Type: volume Value: 11 – Type: issue Value: 8 Titles: – TitleFull: JCI insight Type: main |
| ResultId | 1 |